Company Profile

Smith+Nephew is a portfolio medical technology business focused on the repair, regeneration and replacement of soft and hard tissue. We exist to restore people’s bodies and their self-belief by using technology to take the limits off living. We call this purpose ‘Life Unlimited’. Our 19,000 employees deliver this mission every day, making a difference to patients’ lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global franchises of Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Founded in Hull, UK, in 1856, we now operate in more than 100 countries. Smith+Nephew is a constituent of the FTSE100 (LSE:SN, NYSE:SNN). The terms ‘Group’ and ‘Smith+Nephew’ are used to refer to Smith & Nephew plc and its consolidated subsidiaries, unless the context requires otherwise. For more information about Smith+Nephew, please visit and follow us on Twitter, LinkedIn, Instagram or Facebook.

Contact details

Local rep Details

Smith & Nephew

Join us for our session on: Reshaping the boundaries of Negative Pressure Wound Therapy in the Treatment of Acute and Chronic Wounds

  • Presenting new International Consensus Panel recommendations
  • Introducing a clinical decision-making pathway for appropriate use of single-use and traditional NPWT
  • Learn how to improve your clinical, patient and financial outcomes


Shaping what’s possiable in wound care


PICO◊ sNPWT vs tNPWT system
PICO Single Use Negative Pressure Wound Therapy System for open wounds